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Abstract
Although the contribution of carbohydrate catabolism to bacterial colonization and infection is well recognized, the
transcriptional changes during these processes are still unknown. In this study, we have performed comparative global gene
expression analysis of GBS in sugar-free versus high glucose milieu. The analysis revealed a differential expression of genes
involved in metabolism, transport and host-pathogen interaction. Many of them appeared to be among the genes
previously reported to be controlled by the CovRS two-component system. Indeed, the transcription profile of a DcovRS
strain grown in high-glucose conditions was profoundly affected. In particular, of the total genes described to be regulated
by glucose, ,27% were under CovRS control with a functional role in protein synthesis, transport, energy metabolism and
regulation. Among the CovRS dependent genes, we found bibA, a recently characterized adhesin involved in bacterial serum
resistance and here reported to be down-regulated by glucose. ChIP analysis revealed that in the presence of glucose, CovR
binds bibA promoter in vivo, suggesting that CovR may act as a negative regulator or a repressor. We also demonstrated
that, as for other target promoters, chemical phosphorylation of CovR in aspartic acid increases its affinity for the bibA
promoter region. The data reported in this study contribute to the understanding of the molecular mechanisms modulating
the adaptation of GBS to glucose.
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Introduction
Streptococcus agalactiae (GBS) is a Gram-positive b-haemolytic
human pathogen commonly residing in the gastrointestinal tract of
up to 50% of the healthy population. Although GBS is commonly
associated with neonatal diseases [1] and postpartum infections, it
is also an important cause of morbidity and mortality among
adults [2]. GBS infections have been reported to occur in adults
with serious underlying conditions [3,4,5], including HIV infec-
tions, liver cirrhosis and diabetes [6,7]. For example, it has been
reported that in diabetic patients GBS takes advantage of this
condition by crossing the endothelial barrier and promoting
invasion [8]. The impact of hyperglycemia upon susceptibility to
GBS infection has not been fully elucidated, although, at least in
part, this effect seems to be due to impairment of neutrophil
effector functions [9]. This is supported by clinical evidence
indicating a strong correlation between individuals with high
blood glucose levels and the propensity to acquire GBS systemic
infections [6,7]. Nevertheless, carbohydrate catabolism has been
highlighted to be important in the pathogenesis of streptococcal
disease, with the number of mechanisms associated to the ability of
streptococci to utilize both simple and complex sugars defined
[10]. Of interest, a clear link between virulence factor production
and complex carbohydrate catabolism in Streptococcus pneumoniae,
Streptococcus pyogenes and GBS has been recently proposed by
Shelburne and colleagues [11].
The ability of GBS to survive in specific human niches mainly
depends on its capacity to activate a number of regulatory
networks. This is achieved by controlling at a transcriptional level
the production of proteins involved in adhesion, nutrient
acquisition, and survival against host immune system [12,13]. In
particular, global gene expression analysis of GBS grown in
amniotic fluid, blood and pH stress conditions [14,15,16] has
recently revealed a number of mechanisms used by GBS to adapt
to the host [13,14,15]. However the transcriptional network
underlying the GBS response to glucose availability has been so far
only marginally investigated.
Pathogenic streptococci use two-component regulatory systems
(TCS) to sensing signals from the environment and efficiently
respond to them. The capsule synthesis regulator (CovRS) is the
most studied TCS in GBS, reported to be responsible for the
modulation of transcription for up to 7% of total genes [12,13].
The genes regulated by CovRS belong to different functional
categories, such as cell envelope, cellular processes, metabolism
and virulence factors.
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In this study we setup an in vitro model to define the response of
GBS to glucose. Comparative gene expression analysis revealed
that not only many transport and metabolic genes were affected,
but also genes involved in host-pathogen interactions. We also
provide evidence that CovR controls approximately one third of
glucose-dependent genes, including virulence determinants such as
bibA and the cyl gene cluster. Moreover, we identified a
conspicuous group of glucose-regulated genes independent from
CovR control, whose regulation appears to involve other
regulatory proteins. The data reported in this paper aim to
improve the understanding of the physiological mechanisms
underlying GBS adaptation to glucose-rich environments.
Materials and Methods
Bacterial strains and growth conditions
GBS type V strain 2603V/R and isogenic mutant strain
2603DcovRS come from an internal strain collection and have been
previously described [12,17]. Escherichia coli DH10BT1, HK100
and BL21 (DE3) were obtained from Invitrogen and used for
cloning (DH10BT1, HK100) and expression (BL21 DE3) strains.
Unless otherwise specified, for experiments testing the effect of
glucose on transcriptional regulation, bacteria were grown in THB
until late exponential phase, centrifuged and then resuspended in a
complex medium (CM) containing 10 g/liter proteose peptone,
5 g/liter Trypticase peptone, 5 g/liter yeast extract, 2.5 g/liter
KCl, 1 mM urea and 1 mM arginine. When they reached the mid
exponential phase they were centrifuged, supernatant removed
and resuspended in CM in the absence or presence of 55 mM
glucose for 30 minute. Escherichia coli strains were grown in Luria–
Bertani broth and supplemented with 100 mg ml21 ampicillin.
Microarray procedures and data analysis
Microarray comparison was performed for the wild-type strain
2603 V/R and the isogenic mutant strain DcovRS, both grown as
described in the previous paragraph. For each condition, four
independent cultures were carried out in parallel. Total RNA was
extracted from each culture with the RNeasy Mini Kit and treated
with RNase-free DNase (both from Qiagen) according to the
manufacturer’s instructions. The concentration of total RNA was
determined using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies). RNA integrity was verified using a
Bioanalyzer 1000 (Agilent). RNAs from each culturing condition
were pooled and subjected to cDNA synthesis and labeling, which
were performed at Roche NimbleGen, Inc. (Madison, WI, USA).
Changes in gene expression levels were evaluated by using the
NimbleGen GBS DNA microarray (17 probes for each gene, 3
replicates for probe consisting of 60-mer synthetic oligonucleotides
for each gene). Hybridizations, staining, and processing were also
performed at Roche NimbleGen. Scanned image and data were
extracted and analyzed internally using NimbleScan software, as
previously described [18]. Gene calls were generated using the
Robust Multichip Average (RMA) algorithm as described in
[19,20]. The raw data were analyzed using the DNASTAR
software. Genes whose expression ratios exceeded two fold at a P
value of #0.01 were considered differentially expressed (T-Test
with Bonferroni’s correction). The microarray experiment has
been submitted to the Array Express database of the European
Bioinformatic Institute (http://www.ebi.ac.uk/microarray-as/ae/)
and the submission accession number is E-MTAB-1100.
Quantitative reverse transcriptase PCR
Reverse transcription-polymerase chain reaction (RT-PCR) was
carried out on 1 mg total RNA using ImProm-II reverse
transcriptase and random primers (Promega). Real-time quantita-
tive PCR was performed using Fast start universal SYBR Green
Master (Roche) according to manufactur’s instruction, in a Light
Cycler 480 System (Roche). All samples were run in triplicate on
96-well optical PCR plates (Roche Diagnostics). The specific
primers used to amplify cDNA fragments corresponding to potB,
bibA, cfb, cylX, sap, sag1333, sag2021, sag0677 and gyrA are reported
in Table S2. After an initial denaturation for 10 min at 95uC,
denaturation at the subsequent 40 cycles was performed for 15 s at
95uC, followed by 15 s primer annealing at 60uC and a final
extension at 72uC for 30 s. The DDCT method [21] was applied as
a comparative quantification method. potB, bibA, cfb, cylX, sap,
sag1333, sag2021, sag0677 mRNA levels were normalized to gyrA,
used as a housekeeping gene. The specificity of the amplified
fragment was demonstrated by the melting curve, where a single
peak was observed for each sample amplified with potB, bibA, cfb,
cylX, sap, sag1333, sag2021, sag0677 and gyrA primers.
Cloning, production and purification of recombinant
CovR
To produce a recombinant CovR as histidine–fusion protein in
E.coli, covR DNA coding sequence (sag1625) was amplified by PCR
from GBS type V strain 2603V/R. Oligonucleotides used for
amplification of the covR gene incorporated an NdeI or XhoI site in
the forward or reverse primers, respectively (Table S2), and were
used to clone the gene into pET21b+ vector (Novagen). In order to
express proteins, the plasmid containing covR gene was introduced
into BL21 (DE3) (Invitrogen). E. coli BL21 (DE3) harboring covR
was grown at 37uC to an OD600 of 0.5 in LB containing 100 mg
ml21 ampicillin. Expression of the recombinant protein was
induced with 1mM isopropyl-beta-D-thiogalactopyranoside
(IPTG, Sigma Aldrich) and the culture shaken for 3h at the same
temperature. After 3 hours, the cells were harvested by centrifu-
gation, resuspended and disrupted by sonication. The purification
on the soluble fraction was performed with His Gravi Trap
columns (GE Healthcare). Protein concentration was calculated
using the Bradford assay [22]. After purification, the protein was
dialyzed.
Electrophoretic mobility shift assays (EMSA)
To test the binding of CovR to the bibA promoter, a biotinylated
DNA fragment corresponding to the promoter region of bibA
(sag2063) was amplified by PCR from the GBS type V strain
2603V/R (Table S2). Labeled probe was incubated with
recombinant CovR for 20 minutes at room temperature. The
reaction was stopped with 50% glycerol and protein-DNA
complexes separated on native 6% polyacrylamide gel. DNA,
transferred to a nylon membrane, was cross-linked to the
membrane by UV light. After 1h incubation in blocking buffer,
the membrane was then incubated with HRP conjugated
streptavidin (Pierce) and signals visualized by chemiluminescence.
Competitive EMSA experiments were performed to determine the
specificity of CovR for the bibA promoter, by using an excess (250–
500 fold) of either unlabelled PbibA (as a specific competitor) or the
promoter region of sag0017 (pscB) gene (Psag0017, as a non-specific
competitor) amplified by PCR from GBS type V strain 2603V/R
chromosome using specific primers (Fw sag0017 and Rv sag0017,
Table S2). The in vitro phosphorylation of CovR was obtained
incubating the recombinant protein with acetyl phosphate for 90
minutes at room temperature, as reported by Jiang et al. [23].
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Chromatin immunoprecipitation (ChIP)
2603 V/R GBS wild type strain and isogenic mutant strain
DCovRS grown in CM in the presence or not of glucose were fixed
with 1% formaldehyde and cross linking reaction was stopped by
the addition of 125mM glycine. Bacteria were then sonicated
reaching an average size of sheared DNA of,0.5 kb. Cell extracts
were pre-cleared with protein A-Sepharose slurry (Pharmacia) for
45 minutes at 4uC and incubated overnight with an anti-CovR
mouse serum. CovR-DNA complexes were immuno-precipitated
with 50% protein A slurry for 3 hours at 4uC in sterile disposable
mini-columns (Bio-Rad). After four washing steps, the immuno-
complexes were treated with RNase A and digested overnight with
proteinase K. Cross-linking was reversed for 6 hours at 65uC and
DNA extracted with organic solvents. The presence of the target
promoter sequences in the chromatin immunoprecipitates was
detected by quantitative real-time PCR. Quantitative real-time
polymerase chain reaction (qPCR) analyses were performed on a
Light Cycler 480 System (Roche) using LightCycler 480 SYBR
Green I Master mix (Roche). After an initial denaturation step for
10 min at 95uC, amplification was conducted for 50 cycles with
10 s at 95uC, followed by 10 s primer annealing at 50uC and final
extension at 72uC for 20 s. The purified DNA from ChIP
experiments before (input) and after (eluate) the immune-
precipitation was used for qPCR. Primers sets for the amplification
of cylX, cfb, bibA and sag0017 promoter regions are listed in Table
S2. The levels of each PCR product in the eluate was first
normalized to input levels and then reported as fold changes with
respect to wild type strain grown in CM without glucose.
Results
Regulation of GBS gene expression by glucose
To elucidate the response of GBS to glucose, we performed a
comparative global gene expression analysis of the 2603 V/R GBS
grown in THB until late exponential phase, centrifuged and then
grown up to mid exponential phase in a peptone-based complex
medium (CM) before been transferred for 30 minutes in a CM
devoid of sugars (referred as no glucose condition) or containing
55 mM glucose (therein after referred as high glucose condition).
A total of 640 genes were differentially regulated (.2-fold change,
P,0.01), of which 257 were up-regulated and 383 were down-
regulated. As expected, among the most regulated functional
families, we found genes related to both energy metabolism and
transport/binding (Fig.1). A list of the most regulated genes is
reported in Table 1. The microarray data were validated by real-
time RT-PCR analysis for eight genes (see Table S1).
Metabolic genes
The expression of genes involved in a wide range of metabolic
pathways was found to be dramatically modulated after 30
minutes in 55 mM glucose, indicating a rapid adaptation of GBS
central metabolism to the availability of new nutrients. Transcript
changes were observed in genes involved in aminoacid biosynthe-
sis, with sag2165(argF-2) and sag2167(arc-2), encoding for a
carbamate kinase and an ornithine carbamoyltransferase, being
highly down-regulated (up to 20-fold). Both enzymes are
components of the arginine deiminase system, which has been
suggested to sustain bacterial survival in acidic environments by
catalyzing the release of ammonia from arginine [24]. The sag1907
gene (eda-2), encoding for keto-hydroxyglutarate-aldolase/keto-
deoxy-phosphogluconate aldolase, was also found to be among the
most down-regulated. Conversely, few genes were slightly up-
regulated, such as the ones belonging to the aspartate and serine
metabolism families. A drastic down-regulation (up to 130-fold) of
genes implicated in the metabolism of complex sugars was
observed, as well as the locus comprising the ORFs from
sag0033 to sag0042, codifying for components of the nan operon,
responsible for the transport and metabolism of sialic acid. The list
also encompasses: a carbohydrate kinase (sag1906) belonging to the
PfkB family; a putative hexulose-6-phosphate synthase sag1812(u-
laD); L-a ribulose-5-phosphate 4-epimerase sag1810(araD); a
putative hexulose-6-phosphate isomerase (sag1811); and the
sag0118(rbsK) gene encoding for a ribokinase. Genes encoding
for proteins required for fermentation processes were also found to
be down-regulated, including sag1637, sag0053 and sag0054,
annotated as alcohol dehydrogenases (adh, adhP, adhE). The
down-regulation of genes codifying for proteins implicated in the
biosynthesis and degradation of polysaccharides such as sag1901,
glucuronyl hydrolase; sag0041, acetyl xylan esterase; sag1216,
pullulanase; sag0856, glycogen synthase (glgA); sag0854, glucose-1-
phosphate adenylyltransferase (glgC); sag0853 glycogen branching
enzyme (glgB), was also observed.
Transport genes
Several genes encoding transport proteins were found to be up-
regulated in high glucose conditions. These included sag0745,
coding for a putative transporter of the NRAMP family, involved
both in Mn2+ and Fe2+ uptake [25,26] and genes encoding for
proteins involved in potassium uptake, such as sag1590, sag1591,
sag1631 (belonging to the trk family) and sag1090. We also observed
a fivefold up-regulation of the sag1711 gene, coding for a putative
CorA protein involved in magnesium transport [27]. Among the
positively regulated genes, we found the dps gene sag1444, coding
for a putative peptide/proton symporter [28]; a putative histidine
ABC transporter (sag0947 to sag0949); a spermidine-putrescine
transporter, potABCD (sag1108 to sag1111), implicated in the
pathogenesis of Streptococcus pneumoniae [29]; the sag0290 to sag0292
operon (regulated up to 8-fold), encoding a putative polar amino
acid ABC transporter; the sag1145 gene, encoding for the
sodium:alanin symporter protein; the sag0715 to sag0718 and
sag0947 to sag0949 genes, encoding for amino acid ABC
transporters. Furthermore, the transcription of genes encoding
an ABC transporter specific for glycine betaine (sag0241 to
sag0244), whose accumulation in Bacillus subtilis and Lactococcus
lactis confers protection against osmotic and cold stress, was up-
regulated [30,31,32]. As expected, in high glucose conditions,
genes involved in the transport of complex carbohydrates were
down-regulated, including: the region spanning from sag1441 to
sag1443 ORFs, encoding for the maltose-maltodextrin transport
system (malE-F-G); sag0955 and sag1925 (msmK) genes, encoding a
sugar-ABC transporter and a sugar transport ATP-binding
protein, respectively; the ribose ABC transporter region (from
sag0114 to sag0117, namely rbsA-B-C-D); the cellobiose ABC
transporter sag0328(celC) to sag0330(celB). Moreover several
phosphotransferase systems (PTS), that allow the uptake of various
carbohydrate sources, such as sag1805, sag1813, sag1814, sag1948–
1951, sag1898–1902 and sag0192 were found to be highly down-
regulated (up to 120-fold).
Host-pathogen interaction genes
Pathogenic bacteria, by modulating the expression of surface-
associated or secreted virulence factors, can adapt to host
conditions and improve their capacity to persist in specific niches.
In our experimental conditions the transcription of several known
or putative virulence factors was down-regulated. In particular, the
cyl gene cluster (sag0662 to sag0673), required for GBS hemolysin
production [33], and the cfb gene (sag2043), encoding the CAMP
factor [34], were down-regulated in a range between 6 to12 fold. A
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similar pattern of expression was also observed for LPXTG cell
wall-anchored proteins, such as BibA (sag2063). Among factors
involved in host cell adherence and invasion and repressed by
glucose, we report sag1234, a gene encoding for the laminin
binding protein Lmb, which promotes GBS adherence to host cells
through the binding to laminin [35]. Furthermore, we found that
the expression of both SodA (sag0788), a gene which plays a crucial
role in oxidative stress [36], and hyaluronate lysase (sag1197),
which cleaves hyaluronic acid, a connective tissue component
promoting GBS spreading during infection, was significantly
reduced. On the contrary, sag0677, a gene encoding an unknown
function LPXTG protein, and sag2021, codifying a GP-340
binding protein [37] were up-regulated by glucose. The same
trend was observed for genes spanning from sag1739(cydC) to
sag1744, grouped in an operon previously reported to be involved
in the respiration metabolism and to play a role in virulence and
GBS growth in vivo [38].
Stress response genes
The incubation of GBS in a high glucose medium results in a
considerable change in the expression of genes involved in
adaptation and stress response. A dramatic change was observed
in the transcript of sag1677, that codes for a universal stress
protein, whose expression was highly down-regulated (27-fold)
following exposure to glucose. Several genes, including sag1135,
sag1136 and sag1137, encoding for proteins involved in the stress
response, were also down-regulated. Interestingly, these proteins
are homologs to Gls24, a general stress protein of Enterococcus
faecalis which has been reported to have a crucial role in stress
response as well as in virulence [39].
Transcriptional regulators
After 30 minutes of incubation with 55 mM glucose several
transcriptional regulators were modulated. In particular, sag1128,
sag2017, sag0554, belonging to the putative Cro/CI family and
sag1749, sag1655, sag0427, being part of the putative Mer family of
regulators, were 2–5 fold up-regulated. Of interest, the latter family
has been reported to act as a key activator of the nitric oxide defense
system in pneumococci, thus ensuring both survival and systemic
infection [40,41]. In response to the availability of glucose sources,
bacteria down-regulate the expression of multiple genes involved in
alternative sugar metabolism pathways through the carbon
catabolite repression system (CCR), mediated by the catabolite
control protein A (CcpA, sag0707). Bioinformatic analysis revealed
that a number of transcriptional regulators, that were highly down-
regulated under glucose conditions (up to 20-fold), has a cre box
sequence in their promoter region (http://regprecise.lbl.gov/
RegPrecise/gmregulon.jsp?gmproject_id= 6875). They included:
sag0277, encoding a Mga-like protein, a positive regulator of
virulence in GAS [10]; sag1348, fruR, lactose phosphotrasferase
system repressor; sag0119, rbsR, ribose operon repressor; sag0042,
phosphosugar-binding transcriptional regulator belonging to RpiR
family; sag2073, a transcriptional regulator belonging to GntR
family and sag2161, encoding for a transcriptional regulator of the
Crp/Fnr family.
The response to glucose involves the two component
system CovRS
By comparing previously reported information on genes
controlled by the CovRS two-component system [13] and the
array of genes modulated by glucose, we found a number of them
whose expression appeared to respond to both CovRS and
glucose. We therefore investigated the transcriptional response of
an isogenic DcovRS mutant strain to glucose availability under the
experimental conditions used for 2603 V/R GBS wild type (see
Materials and Methods). Although WT and DcovRS mutant strain
growth rate during the experimental time span (30 min) was
comparable in the absence or presence of glucose, at prolonged
incubation time rate GBS growth rate was higher at 55mM
glucose (Fig. S1). Of total genes differentially regulated under high
Figure 1. Differential regulation of gene expression in GBS strain 2603 V/R after exposure to 55 mM glucose. Genes were classified
into 17 functional categories. Bars indicate the numbers of genes differentially regulated in medium with 55 mM glucose versus medium devoid of
sugars.
doi:10.1371/journal.pone.0061294.g001
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glucose these genes, 466 (72.8%) were also regulated in the covRS
mutant (defined as glucose-dependent-covRS independent genes)
and showed the same regulation state of the wild type strain, while
174 genes were exclusively regulated in the wild type strain
(referred as glucose dependent-covRS dependent genes), with 52
up-regulated and 127 down-regulated (Fig. 2). Finally, a group of
308 genes was only regulated by glucose in the covRS mutant, likely
to involve different adaptive mechanisms compensating for the
absence of a functional CovRS regulator. As shown in Fig. 3, the
distribution of CovRS dependent and independent genes under
high glucose conditions revealed important differences and a
relevant role of CovRS in modulating genes involved in transport
and binding of proteins, protein synthesis, energy metabolism and
regulation. Conversely some functional classes appear to be
independent from CovRS in presence of glucose, in particular
genes up-regulated and having a role in regulation and transcrip-
tion; genes both up and down-regulated and having a role in cell
envelope biosynthesis and degradation. Glucose-CovRS depen-
dent gene regulation was validated by real-time RT-PCR analysis
for eight representative genes (Fig. 4) both in the wild-type and the
CovRS mutant strains (Table S1).
CovR binds bibA promoter in vivo
To better define the mechanism of action of CovRS on the
transcription of putative virulence factors, we investigated the
Table 1. List of genes highly regulated in GBS strain 2603V/R after incubation in high glucose medium.
Family TIGR locus Annotation Fold change Regulation
DNA metabolism
SAG0008 Transcription-repair coupling factor (mfd) 6.1 Up
Cell envelope
SAG0185 Hypothetical protein 10.24 Down
SAG0281 Hypothetical protein 7.04 Down
SAG2169 Hypothetical protein 8.35 Up
Unknown function
SAG0040 ROK family protein 48.35 Down
SAG1643 Glutamine amidotransferase, class I 19.91 Up
Transport and binding proteins
SAG0034 Sugar ABC transporter 128.03 Down
SAG1642 ABC transporter 19.12 Up
SAG1949 PTS system 84.29 Down
SAG1950 PTS system 119.63 Down
SAG1951 PTS system 92.69 Down
Cellular processes
SAG0662 CylX protein (cylX) 8.99 Down
SAG0663 CylD protein (cylD) 11.63 Down
SAG0664 CylG protein (cylG) 12.25 Down
SAG0666 CylZ protein (cylZ) 9.92 Down
SAG0667 CylA protein(cylA) 10.16 Down
SAG0668 CylB protein (cylB 8.82 Down
SAG0669 CylE protein (cylE) 8.79 Down
SAG0670 CylF protein (cylF) 8.63 Down
SAG0671 CylJ protein (cylJ) 7.01 Down
SAG0672 CylI protein (cylI) 6.76 Down
SAG0673 CylK protein (cylK) 5.98 Down
SAG1733 Universal stress protein family 96.38 Up
SAG2043 cAMP factor (cfb) 5.76 Down
Transcription
SAG0777 ATP- dependent RNA helicase 21.94 Up
Energy metabolism
SAG0856 Glycogen synthase (glgA) 20.31 Down
SAG1216 Pullulanase (sap) 20.61 Down
Amino acid biosynthesis
SAG1907 Keto-hydroxyglutarate-aldolase (eda-2) 48.04 Down
SAG2165 Ornithine carbamoyltransferase (argF-2) 10.84 Down
doi:10.1371/journal.pone.0061294.t001
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regulatory activity of CovRS on the promoter of bibA, an
immunogenic bacterial adhesin with anti-phagocytic properties
[42], here reported to be down-regulated by glucose in a CovRS
dependent manner. The bibA promoter (PbibA) presents a specific
binding motif for CovR, as reported by Lamy et al. [13]. We
evaluated the binding of CovR to the bibA promoter in vivo by
Chromatin immune-precipitation (ChIP) analysis of bacterial
cultures exposed for 30 minutes to 55 mM glucose. Protein-
DNA complexes were immunoprecipitated with CovR antiserum
and analyzed by qRT-PCR for the presence of bibA promoter
region, using cylX and cfb promoters as positive controls and
sag0017 promoter as negative. The amount of each promoter
region in the eluate was first normalized to the amount in the input
and subsequently reported as fold changes compare to wild type
grown without glucose. As shown in Fig. 5A, quantification of the
DNA immunoprecipitated with CovR antiserum revealed a 5.8
fold increase in the amount of bibA promoter region in GBS
cultures exposed to high glucose (55 mM) levels compared to
sugar-free conditions. This level is comparable to the levels of cfb
promoter (4.7 fold) and cylX promoter (6.9 fold), whereas the
negative control sag0017 promoter shows little or no changes upon
high glucose exposure. As expected in the eluate from the isogenic
DcovRS deletion mutant grown with or without glucose the level of
PCR products is close to the detection limit. These data clearly
show that CovR in presence of high glucose is able to bind bibA
promoter region in vivo.
CovR affinity for PbibA depends on phosphorylation
To confirm that CovR interacts directly with the bibA promoter
region, we performed electrophoresis mobility shift assay (EMSA)
experiments by incubating a biotin-labeled DNA fragment
corresponding to the promoter region of bibA with increasing
amounts of recombinant CovR. We observed that the minimal
quantity of protein necessary to induce a significant shift in the
mobility of the bibA promoter was 2 mM (data not shown). To
verify whether the binding of CovR to PbibA was specific, we
performed competitive EMSA by incubating recombinant CovR
protein with both 250- and 500-fold excess of unlabeled PbibA
(specific competitor) or sag0017, a promoter lacking the binding
motif for CovR (non-specific competitor). As displayed in Fig. 5B,
the addition of the specific competitor abolished the binding of
recombinant CovR to the labelled PbibA fragment, while the
addition of increasing quantities of unlabeled sag0017 had no effect
on the ability of CovR to bind to PbibA. These data postulate a
preferential binding of CovR to PbibA. Recently, Jiang and
colleagues [23] demonstrated that chemical phosphorylation of
CovR on aspartic acid, increased its affinity for the promoter of
different genes. As shown in Fig. 5C, treatment of CovR with
acetyl phosphate, a chemical phospho-donor, led to an increased
affinity for the bibA promoter compared to the untreated
recombinant CovR. The shift delay of the band relative to the
phospho-CovR/PbibA complex was visible at a lower concentra-
tion than the one needed for the un-phosphorylated form of the
Figure 2. Transcriptome changes elicited by glucose in GBS. Comparison of gene expression changes (log2) between mid-log cultures of
2603 V/R wild-type strain and CovRS mutant following challenge with or without glucose. Data for the wild type and mutant strains are shown on the
x axis and y axis, respectively.
doi:10.1371/journal.pone.0061294.g002
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protein. Altogether, these data confirm the capability of CovR to
bind specifically the bibA promoter and that phosphorylation of
CovR increases the binding to PbibA.
Discussion
Glucose and other carbon sources are known to influence the
lifestyle of many pathogens that adapt their metabolism to the
nutritional composition of their host niches. Indeed, bacteria have
evolved sophisticated methods for sensing carbon source avail-
ability to face the inter-bacterial competition for energy sources.
For example, Alteri and co-workers have recently described a
uropathogenic Escherichia coli subgroup that has adapted to grow as
a harmless commensal in carbon-rich human intestine, but rapidly
become invasive in the nutritionally poorer urinary tract [43].
Concerning Staphylococcus aureus, its colony spreading phenotype
requires the expression of the agr gene, which is positively
regulated by environmental glucose and carbon sources [44].
Our study proposes that a general trend of adaptive regulation is
also triggered during the growth of GBS in high glucose conditions
(Fig. 6). The in vitro model used in this study, although hardly
resembling a physiological status of GBS, mimics the adaptation of
this bacterium to standard laboratory conditions in which is
common the use of high-glucose media (i.e. THB). One of the
limitations for setting in vitro experiments looking at the effect of
carbon sources on bacterial response is the fact that, differently
from what happens in vivo where the system is rapidly buffered (i.e.
blood) metabolites generated during the incubation of bacteria
with sugars may alter the pH of the milieu. In order to precisely
delineate the impact of glucose on global GBS transcriptome and
avoid the contribution of pH alteration to the modulation of gene
expression, we limited the duration of the experiments to 30
Figure 3. Differential regulation of gene expression in GBS strain 2603 V/R versus the isogenic DCovRS mutant strain after
incubation in medium with 55 mM glucose versus a sugars-free complex medium. White bars indicate the number of glucose-regulated
genes in the wild-type strain; black bars indicate the number of genes that are glucose- dependent and CovRS-dependent; grey bars indicate the
number of genes that are glucose-dependent and CovRS-independent.
doi:10.1371/journal.pone.0061294.g003
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minutes, a time point at which pH remained unvaried (data not
shown).
A number of reports have postulated that catabolism of
carbohydrates plays a key role in the pathogenesis of invasive
streptococci, including Streptococccus pneumoniae, Streptococcus pyogenes
and GBS [10,11,45,46]. Johns and colleagues have recently
applied signature-tagged transport mutagenesis to a neonatal
sepsis model and showed the importance of carbohydrate
catabolism for GBS infectivity [46]. In particular, by knocking
out genes involved in complex carbohydrate metabolism, includ-
ing a maltose-binding protein (mal), a phosphotransferase (PTS)
and a sucrose hydrolase (scrB), they observed an attenuated
virulence [46]. These genes that appear to be essential to GBS
infectivity in vivo were found to be down-regulated in our study,
suggesting that the presence of high glucose levels may attenuate
carbohydrate metabolism, rendering their expression dispensable.
In line with this, we found a number of metabolic systems down-
regulated by glucose such as genes involved in polyamine
transport, biosynthesis and degradation of polysaccharides (in-
cluding the nan operon, responsible for sialic acid catabolism) and
fermentation processes. We also observed that bacteria grown in
high glucose are dividing more rapidly (data not shown), thus, as
expected, genes encoding for DNA replication, recombination,
repair and for membrane biosynthesis were found to be highly up-
regulated, while genes encoding for enzymes involved in substrate
degradation were found to be down-regulated (see TableS3 and
Table S4).
The exposure of GBS to glucose appears to modulate several
genes coding for cell envelope proteins, likely to be involved in
host-pathogen interactions. Although the number of up-regulated
cell envelop genes is superior to the down-regulated ones, among
the latter we found genes encoding for pore-forming toxins, such
as hemolysin b, known to be crucial in promoting cell invasion and
lysis [33,34]. Furthermore, the presence of glucose also reduced
the transcription of genes involved in host cell adherence, such as
Lmb [35] and bibA [47]. On the contrary, sag2021, a GP-340-
binding protein, proposed to be involved in bacterial colonization
was found to be up-regulated [37]. The capacity of GBS to adapt
to environmental changes mainly relies on two types of
transcriptional regulation, the two-component gene regulatory
systems (TCS) and stand-alone regulators (such as CcpA). The best
characterized TCS in streptococci is the CovRS system, which
plays a key role in connecting the expression of complex
Figure 4. Real-time RT-PCR evaluation of bibA expression in
2603V/R and DcovRS strains grown in medium containing
55 mM glucose or in sugar-free medium. Transcript levels were
normalized to the expression level of gyrA. Syber green runs were
performed with cDNAs from the same reverse transcription reaction
from 1 mg of total RNA. The DDCT method was applied as a
comparative method of quantification, using strains grown in sugar
free medium as reference. The data are representative of 2 independent
experiments, each in triplicate. Error bars, SD.
doi:10.1371/journal.pone.0061294.g004
Figure 5. CovR binds to bibA promoter in vivo. (A) Quantification
by qRT-PCR of bibA promoter immunoprecipitated with CovR antiserum
in 2603 V/R wild type strain grown in medium devoid of glucose or in
the presence of 55mM glucose. cfb promoter and cylX promoter were
used as a positive control while sag0017 promoter was used as a
negative control. The level of PCR products of eluate from the isogenic
DcovRS deletion mutant grown with or without glucose was negligible.
The data are representative of 3 independent experiments, each in
triplicate. Error bars, SD. (B) Competitive EMSA experiment. Labelled
PbibA fragment (3.3 nM) was incubated without (lane1) or with CovR
(2 mM) (lane2–6), in the presence of different amounts of unlabelled
PbibA (lane 3–4), as a specific competitor, and Psag0017 (lane5–6), as a
non-specific competitor. The labelled DNA was detected by chemiolu-
minescence. (C) CovR phosphorylation increases its affinity for bibA
promoter. Electrophoretic mobility shift assay using recombinant CovR
(left) and chemically phosphorylated recombinant CovR (right). Labelled
PbibA DNA fragment (3.3 nM) was incubated without or with the
indicated amounts of CovR. The labelled DNA was detected by
chemioluminescence.
doi:10.1371/journal.pone.0061294.g005
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carbohydrate metabolism genes with that of virulence factors,
thereby contributing to the modulation of the pathogenesis process
[13,48,49]. In particular, the different CovRS mutants or alleles
generate distinct signaling patterns and contribute to the bacterial
ability to colonize specific host niches, disseminate and cause
disease outcomes [50]. For instance, in Group A Streptococcus,
pharyngeal and invasive strains show distinct virulence behaviors
that are associated to fundamentally different transcriptomes
designated as pharyngeal transcriptome profile (PTP) and invasive
transcriptome profile (ITP). Interestingly, invasive strains show a
mutated covS gene allele carrying 7-bp frameshift mutation.
Experimental observation strongly support that the covS mutation
is responsible for the PTP to ITP transition occurring during
invasive infections [51]. Similarly, in GBS, there is a strain-specific
regulatory role of CovRS that influences on the transition between
commensal to virulent meningeal pathogen [52]. In our study, a
wide range of glucose-dependent genes, in particular factors
implicated in GBS transport function and host-pathogen interac-
tion, resulted to be under CovRS regulation, strongly suggesting
that effectors of this TCS are involved in the response and
adaptation of GBS to high glucose condition. As previously
reported for the response of GBS to pH stress conditions [16], also
in the case of high glucose conditions the contribution of CovRS to
the regulation of transcription of glucose-dependent genes was
found to be independent on CovR abundance, as its transcription
remained constant along the time span of the experiment. Our
findings showing that CovR enhances its affinity for the bibA
promoter in the presence of glucose by a phosphorylation
dependent mechanism, postulate indeed that the mechanism of
regulation is independent on CovR expression. Of interest, a few
pH-dependent family genes reported by Santi and colleagues
[14,15,16] were also found to be regulated by glucose-stress
conditions. In particular genes involved in protein synthesis,
transport and binding, cell envelop and several hypothetical
proteins. This may indicate that GBS activates common pathways
when exposed to shock conditions and similarly adapts to stress
external stimuli such as low pH and high glucose.
Somewhat surprisingly, the analysis of the genes modulated by
glucose in a CovRS defective strain revealed a consistent number
of genes (, 300) regulated under such conditions but not in wild
type bacteria. This phenotype may indicate that a number of
alternative regulatory mechanisms are activated by glucose when
CovR is not expressed. Indeed, we found that a dozen of
transcriptional regulators, including the arginine repressor argR
(sag0500) and members of the AraC family (sag0432) and Rgg/
GadR/MutR family (sag 1490), were among the genes differently
modulated by glucose in the DCovRS background. In addition, a
number of genes encoding for DNA and RNA metabolism, amino
acid transport and enzymes involved in substrate degradation were
also found to be uniquely modulated by glucose in the CovRS
mutant strain.
Figure 6. Graphical representation summarizing adaptive regulation of GBS in high glucose conditions. Genes of interest are color-
grouped according to main functional categories. Arrows indicate up- or down-regulation relative to time of 309 in high glucose vs. no glucose.
doi:10.1371/journal.pone.0061294.g006
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In this paper, by defining the response of GBS to glucose we
observed an extensive re-modeling of bacterial transcriptome. We
also provide evidence that under such conditions, CovR plays a
pivotal role by controlling a large number of glucose-dependent
genes. Future investigation are deserved to understand whether
strain-specific CovRS mutations alter the adaptive response to
glucose availability and how this reflects into the infectious lifestyle
of this pathogen.
Supporting Information
Figure S1 Growth curve of 2603V/R strain in medium
containing 55mM glucose or in sugar-free medium. Bacteria were
grown in THB at 37uC until late exponential phase, centrifuged
and then resuspended in a complex medium (CM). When they
reached the mid exponential phase they were centrifuged,
supernatant removed and resuspended in CM in the absence or
presence of 55 mM glucose.
(TIF)
Table S1 qRT PCR validation of regulated genes.
(XLS)
Table S2 Primers used in this study.
(XLS)
Table S3 Expression of glucose-dependent/CovRS-dependent
genes.
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Table S4 Expression of glucose-dependent/CovRS-independent
genes.
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